BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11449844)

  • 21. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
    Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
    Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terbinafine Hydrochloride Combined With Itraconazole for Fungal Skin Diseases: A Randomized Controlled Trial.
    Zhang D; Liao W; Chen C; Lai H; Liu S
    Am J Ther; 2021 Mar-Apr 01; 28(2):e179-e186. PubMed ID: 33687025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
    Jansen R; Redekop WK; Rutten FF
    Pharmacoeconomics; 2001; 19(4):401-10. PubMed ID: 11383756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe liver damage on terbinafine.
    Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985370
    [No Abstract]   [Full Text] [Related]  

  • 27. Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
    Van Doorslaer EK; Tormans G; Gupta AK; Van Rossem K; Eggleston A; Dubois DJ; De Doncker P; Haneke E
    Dermatology; 1996; 193(3):239-44. PubMed ID: 8944348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 29. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
    Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
    Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized pustular psoriasis and hepatic dysfunction associated with oral terbinafine therapy.
    Kim BS; Jang HS; Jwa SW; Jang BS; Kim MB; Oh CK; Kwon YW; Kwon KS
    J Korean Med Sci; 2007 Feb; 22(1):167-9. PubMed ID: 17297275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of severe acute liver injury caused by terbinafine.
    Yan J; Wang X; Chen S
    Int J Clin Pharm; 2014 Aug; 36(4):679-83. PubMed ID: 24986266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute fulminant hepatitis after treatment with rabeprazole and terbinafine.
    Johnstone D; Berger C; Fleckman P
    Arch Intern Med; 2001 Jul; 161(13):1677-8. PubMed ID: 11434801
    [No Abstract]   [Full Text] [Related]  

  • 34. Terbinafine-induced hepatic dysfunction.
    Chambers WM; Millar A; Jain S; Burroughs AK
    Eur J Gastroenterol Hepatol; 2001 Sep; 13(9):1115-8. PubMed ID: 11564966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tinea capitis. Therapeutic options in the post-griseofulvin era].
    Möhrenschlager M; Korting HC; Seidl HP; Ring J; Abeck D
    Hautarzt; 2002 Dec; 53(12):788-94. PubMed ID: 12444518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful management of gastrointestinal pythiosis in a dog using itraconazole, terbinafine, and mefenoxam.
    Hummel J; Grooters A; Davidson G; Jennings S; Nicklas J; Birkenheuer A
    Med Mycol; 2011 Jul; 49(5):539-42. PubMed ID: 21174493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic.
    Kramer ON; Albrecht J
    Br J Dermatol; 2017 Nov; 177(5):1279-1284. PubMed ID: 28762471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Itraconazole-induced acute hepatitis.
    Hann SK; Kim JB; Im S; Han KH; Park YK
    Br J Dermatol; 1993 Oct; 129(4):500-1. PubMed ID: 8217769
    [No Abstract]   [Full Text] [Related]  

  • 39. Terbinafine-induced hepatic failure requiring liver transplantation.
    Perveze Z; Johnson MW; Rubin RA; Sellers M; Zayas C; Jones JL; Cross R; Thomas K; Butler B; Shrestha R
    Liver Transpl; 2007 Jan; 13(1):162-4. PubMed ID: 17192859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nortriptyline intoxication induced by terbinafine.
    van der Kuy PH; Hooymans PM
    BMJ; 1998 Feb; 316(7129):441. PubMed ID: 9492672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.